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Abstract:  In order to investigate the association between the human immunodeficiency virus (HIV) 
type-1  and neoplasms, we analyzed the pattern and rates of neoplastic disorders among HIVpositive 
and HIV-negative patients.  A total of 108 incident neoplastic diseases  were  diagnosed among 4272 
subjects tested for HIV at Tikur Anbessa Teaching Hospital, Addis Ababa, from September 1994 to 
March 1997.  Forty-eight (1.1%) incident tumors were diagnosed  among 2701 patients seropositive 
for antibodies to HIV-1 and 60 (1.4%) among 1573 seronegatives. There was no statistical diferrence 
on the occurrence of tumor in the HIV-positive or HIV-negative subjects (Odds ratio=0.48; 95% 
confidence interval=0.32,0.72).  Kaposi's sarcoma (KS)  was the most frequent neoplastic disease 
among HIV-positive subjects (47.9%) and it was strongly associated with HIV seropositivity (Odds 
ratio=13.5; 95% confidence interval=1.95, 268.99). Non-Hodgkin's lymphoma (NHL)  (22.9%) and 
Hodgkin's disease (HD)  (18.8%) were the other frequent neoplasms. Most (73%) of the HIV-related 
NHL were of the high grade type;64% of these tumors were extranodal and 55.6% of all NHL 
occurring in HIV-negative subjects were of the high grade type;only 33.3% were extranodal.  NHL 
of the low grade type was  less frequent in HIV- positive subjects compared to HIV-negative subjects 
(9.1 vs. 25.9%; Odds ratio= 4.08;95% confidence interval 0.51,88.42).  Significant cases of cervical 
carcinomas (37.5%), classified histologicaly as sqamous cell carcinomas, were associated with  HIV 
infection, although it was not statisticaly significant (Odds ratio=0.44;95% confidence 
interval=0.08,2.29).  In the HIV-uninfected subjects, NHL was the most common neoplasm (45%)  
followed by HD (15%), hematological malignancies (10.1%) and cervical carcinomas (8.3%).  Data 
from the present study demonstrate  that  some neoplasms are frequently associated with  the current 
trends  of the HIV/AIDS epidemic in Ethiopia.  Many new AIDS-related neoplasms will likely 
continue to be identified in the future.  [Ethiop. J. Health Dev. 1998;12(2):117-123]  
  
Introduction  
Neoplastic diseases are being reported with increasing frequency in patients infected with the 
human immunodeficiency virus type-1 (HIV-1)  (1-6). In particular, neoplasms such as Kaposi's 
sarcoma (KS) and non-Hodgkin's lymphoma (NHL)  have been clearly associated with HIV 
infection. Furthermore,  a wide spectrum of tumors occur with increased frequency in patients with 
the acquired immunedeficiency syndrome (AIDS), though they have not yet been included as an 
AIDS-defining diseases.  In the developed countries, more than 40% of AIDS patients develop 
neoplastic disorders some time during the course of their disease (4,5). However, there is little 
information regarding the pattern and incidence of  neoplastic diseases in HIV infected subjects   
______________________________________  
in Ethiopia.  In a previous report (7)  from  Ethiopia, Shamebo M. showed that  NHL was 
significantly associated with HIV infection.  Another recent report (8) also showed that KS is being 
diagnosed increasingly during the last five years in the Department of Pathology of the Tikur 
Anbessa Teaching Hospital  (TATH). This led the authors  to propose that the HIV/AIDS epidemic 
in the country might be responsible for the observed increased incidence of the tumor.  This study 
was, therefore, undertaken in order to determine the pattern and rates of neoplastic diseases that may 
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be associated with HIV-1 infection and to compare results with uninfected subjects so as to see the 
impact of  the HIV/AIDS epidemic on the pattern of occurance of neoplastic disorders.     
  
Methods  
A total of 4274  HIV serology tests were performed between September 1994 and March 1997  at 
the AIDS laboratory of the  TATH. During the same period 103 patients with a diagnoses of 
neoplastic diseases were tested for HIV serology.  The medical records of these patients were 
reviewed. The following informations were collected: patient's age, sex, biopsy reports and clinical 
characteristics.  All  biopsy slides were reevaluated by one of the authors (W.E.) for reconfirmation. 
The diagnoses of neoplasms were based on morphological features of biopsy sections.  Slides were  
stained with hematoxylin and eosin (9). Only histologically proved neoplasms were included for this 
study. Hematological malignancies were diagnosed on peripheral and bone marrow smears stained  
with Wright's stain.  NHL were classified according to the criteria described  in the Working 
Formulation of the Non-Hodgkin's lymphoma Pathologic Classification System (10).  HD were 
classified according to the Rye Histological Classification system (11). Antibodies to HIV-1 were 
determined by an ELISA assay (vironostika HIV Uni-Form II, Organon teknika, Netherlands)  
according to the manufacturer's manual. Patients were excluded if information from the medical 
records were incomplete (n=9), or if the biopsy findings were not reconfirmed (n=5) or if the 
diagnosis were non-neoplastic diseases (n=7).  
The patterns of neoplastic diseases were analysed and compared with the results of the serological 
tests for HIV-1 with use of the EPI-Info version 6.0 software package. X 2 analyses and Fischer's 
exact tests were used to compare associations. P values less than 0.05 were considered as significant.        
  
Results  
During the study period,  a total of 4274 HIV serology tests were performed at the AIDS 
Laboratory of the TATH.  Of these,  2701 (63.2%)  were seropositive for antibodies to HIV-1 and 
the remaining 1573 (36.8%) were negative. During the same period there were  103 subjects (2.4%)   
diagnosed  with  neoplastic disorders out of which 48 (1.1%) incident tumors occurred  in 47 
HIVpositive subjects and 60 (1.4%) in 56 seronegatives.  There was a statistical difference on the 
occurrence of tumor in the HIV-positive or HIV-negative subjects (Odds ratio=0.48; 95% 
confidence interval=0.32,0.72).  These 103 were 72 males and  31 females, (male:female ratio 2.3:1) 
with age ranges of between 18  and 78 years.  The mean age was 36.7 years.  The mean age in the 
HIV-positive patients was 35.5 years  compared to 37.8 years in the seronegative patients.  
    
Table 1: Age distribution of neoplasms in HIV-negative HIV-positive patients.  
Age group HIV  HIV   
negative  positive  
15-19   9(16.1)*   0(0.0)  
20-20   8(14.1)  11(23.4)  
30-39  14(25.0)  20(42.5)  
40-49  11(19.6)  14(29.8)  
50-59   9(16.1)   2(4.3)  
 ≥60   5(8.9)   0(0.0)  
Total  56  47  
   9(16.1)*   0(0.0) 
*Numbers in parentheses are percentages.  
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As shown in Table 1, the peak age of neoplasm was between 30-39 years.  However,  the 
frequency was  higher in the HIV-positive subjects than in HIV-negative subjects (42.5% vs. 25%).  
The histological classification of the neoplasms is summarized in Table 2.  The most frequent type 
of  neoplastic disease in the HIV-positive subjects was KS (47.9%).  One  patient with KS had also 
cervical carcinoma.   Furthermore, KS was strongly associated with HIV seropositivity (Odds 
ratio=13.5; 95% confidence interval=1.95, 268.99).  The only patient with KS who were 
seronegative for HIV  was  a  73  year  old  man.  The  most  
  
Table 2: Patterns and frequenccy of incident1 neoplasms in HIV-negative and HIV-positive patients.  
Morphological classification  HIVnegative   HIV- 
positive  
Odds ratio (95% CI)  P-value  
Kaposi’sarcoma    
 1  23    13.50(1.95, 268.99)  P<0.01  
Non-Hodgkin’s lymphoma          
   High grade lymphoma  15   8    0.31(0.12, 0.77)    NS  
   Intermediate lymphoma  
 5   2    0.23(0.03, 1.34)    NS  
   Low grade lymphoma  7   1    4.08(0.51, 88.42)  P<0.05  
Hodgkin’s lymphoma           
   Lymphocyte predominant  
 1   2    1.16(0.08, 32.43)  NS  
   Mixed cellularity  5   5    0.58(0.15, 2.31)    NS  
   Nodular sclerosing  
 3   1    0.19(0.01, 2.07)    NS  
   Lymphocyte depleted  -   1           NA    
Hematological malignancies          
   Chronic lymphocytic leukemia  
   
4  --           NA    
   Plasmacytoma  
    
1  --           NA    
   Multiple myeloma  
   
-   1           NA    
Cervix carcinomas          
   Squamous cell carcinoma 
    
4   3    0.44(0.08, 2.29)    
   Adenocarcinoma  
    
1  --           NA    
Oronasopharyngeal carcinomas  
   
3  --           NA    
Breast cancers  
   
 2  --           NA    
Miscellaneous2   
    
7   1    0.08(0.00, 0.66)    
Total    60 48  0.48(0.32, 0.72)  significant 
difference 
Includes1 the occurrence of more than one type of neoplasm in a patient.           
Include2 such tumors like Wilm’s tumor, hemangiosarcomas, skin cancers (other than KS) and neurofibrosarcomas.  
Abbreviations: CI; confidence interval; NA: not applicable; NS; not significant  
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frequent presentation of the tumor was  a disseminated skin lesions (n=12). Other sites involved 
include skin of the lower extremities (n=10), oral (n=1) and lymph node (n=1). The second common 
type of tumor in the HIV-positive patients was  NHL (22.9%) followed by  HD (18.8%).  Among 
the HIV-negative group, however, NHL (45%) was the most common type of  tumor followed by 
HD (15%), hematological malignancies (10.1%) and cervical carcinomas (8.3%), in descending 
frequency.  
Among the 11 cases of  HIV-related NHL, most (73%)  were of the high grade type. Of all 
HIVrelated NHL, 64% were extranodal: five in the gastrointestinal tract, one in the lung and one in 
the perianal region.  On the other hand, of the 27 cases of NHL occurring in HIV-negative subjects, 
55.6% were of the high grade type and only 33.3% were extranodal [five in gastrointestinal tract; 
two in  lung, two in  breast and one in  liver].  NHL of the low grade type was  less frequent in HIV 
- positive  subjects  compared  to   HIV- negative subjects (9.1% vs. 25.9%; Odds ratio=4.08;95% 
confidence interval 0.51, 88.42).  The disease was advanced  (stage IIB and IVB) in 73% of the 
patients with HIV infection compared to only 33% of  HIV uninfected persons.  Most  (56%) of  the 
nine cases of HIV-associated HD were of mixed cellularity sub-type.  Furthermore, the disease was 
advanced with stages IIIB and IVB presentations in 56% of the cases as  compared to 33% among 
HIV-negative subjects.   
In addition to the known AIDS-related neoplasms, subjects who were seropositive for HIV had 
cervical carcinomas. Although statisticaly not significant (Odds ratio= 0.44;95% confidence 
interval=0.08,2.29), a large proportion of cervical carcinomas (37.5%),  were associated with  HIV 
infection.  These  HIV-related cervical carcinomas were all undifferentiated, invasive sqamous cell 
carcinomas. In general, HIV uninfected  subjects had more often other solid tumors. None of the 
patients with oronasopharyngeal tumors were HIV infected.  
  
Discussion  
Individuals with AIDS are at risk of developing  not only  opportunistic infections, but also a wide 
spectrum of neoplastic disorders.  The latter in particular is attributed to the improved management 
of patients with HIV infection, namely, appropriate treatment and prophylaxis of opportunistic 
infections coupled with antiretroviral chemotherapy (2,4,5).  
The mean age of our patients with neoplastic disorders, irrespective of their HIV status, coincides 
with that of HIV patients in  the general population (12). However,  those with neoplastic disorders 
and who were HIV-positive present at younger age than HIV seronegative persons because 65.9% 
of the HIV-positive patients were younger than 40 years compared to only 55.2% HIV-negative 
patients.  Although there is no significant difference on the rate of neoplasms between HIV-positive 
and HIV-negative patients, the pattern in the AIDS subjects is comparable to that seen in other 
countries (1-6).  The  reason for a lower rate of malignancy among  the HIV-positive subjects  might 
be the fact that physicians  request HIV tests only when they diagnose the commonly known 
AIDSrelated neoplasms.  Morover, the life expectancy among Ethiopian AIDS patients is too short 
for  a neoplastic disease to appear and   the majority of  the patients die from associated opportunistic 
infections (12).  
KS was considered a rare tumor previously (13,14) and during the early AIDS epidemic (15) in 
Ethiopia. The present study, however, showed that KS is the most frequent neoplasm identified 
among the HIV-positive subjects. This is in agreement with a more recent report (8) which showed 
a trend towards a  significantly increased incidence of the tumor during the last five years. Until 
November 1994,  a total of 40 (0.3%) cases of KS has been diagnosed among 15565 AIDS cases 
reported in the country (16).  The present study, however, demonstrated that 23 (0.9%) cases were 
detected among 2701 AIDS patients seen only over thirty months of the study period.  The results 
indicate that there is a significant increase in the incidence of the tumor.  This might be due to the 
increased awareness of  physicians with a high index of suspicion.  Likewise, an increase in the 
incidence of KS  has been described  in other African countries  since the onset of the AIDS epidemic 
(17,18).  Patients with the epidemic form of KS (i.e. HIV-related)  are younger, and the male:female 
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ratio (4.6:1) is much  lower than in endemic forms of KS (18).  This is in agreement with our present 
study where  the male:female ratio was 4.8:1. The epidemic form of KS has a much more fulminant 
clinical presentation.  The disseminated form of KS was noted in  52.2% of the HIV-positive patients.    
The pathogenesis of KS in AIDS is not known definitely yet. Opportunistic infections have also been 
associated with the de novo  appearance of KS in AIDS patients (19).  High circulating levels of 
inflammatory cytokines which have been demonstrated in the face of opportunistic infections may 
account for these effects on KS (19).  Other possible factors suggested include profound HIV-
induced immunosupression, chronic antigenic stimulation, and a sexually transmitted agent (19).   
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Lymphoproliferative disorder incidence among HIV-positive patients as reported previously (7) was 22.2% for 
NHL and 9.1% for HD.  Our study showed a significant increase to 28.9 % (11/38) and 50% (9/18) for NHL and HD, 
respectively. NHL of the low-grade type was more frequent among HIV-negatives patients as previously reported (7). 
However, NHL of the high grade type was more frequent among HIV-negatives, although the association was not 
statistically significant.  The findings confirm the conclusion of prior studies (1-7) that these  neoplasms are additional 
manifestations of AIDS.  Although AIDS patients have significantly greater risk of developing  NHL,  it is also a much 
more common neoplasm than KS in the general population. Histologically, the types of NHL related to AIDS are most 
commonly of the high grade type, but intermediate grade NHL might also be seen among AIDS subjects (20).  
Extranodal sites of  NHL  were frequent in our AIDS cases as is also reported previously (1,3,7).  Although primary 
central nervous  system (CNS) lymphomas are frequently reported in AIDS patients (20), it is rarely recognized in 
Ethiopia. The reason might be due to the low rate of biopsy specimens taken from the CNS as it is also known that 
most AIDS patients with intracranial space occupying lesions are treated frequently for possible opportunistic  
infections as a whole.   
There is accumulating evidence linking AIDS with HD in homosexual men (21). Although not yet accepted as a 
diagnostic criteria for AIDS, HD may  occur with increased frequency in HIV-positive subjects as is also seen in the 
present study.  HD and AIDS are both   relatively common in young persons,  a substantial number of HD cases in 
AIDS patients can be expected to occur by coincidence alone rather than true association.  As is also shown in Table 
1, in the age group 15-19 years, there were 9 HIV-negative patients diagnosed with tumors as compared to none among 
HIV-positive subjects. The reason for this is that, in our series of patients, about 44.4% of all HD cases in HIVnegative 
patients occurred in the above age group, whereas about 55.6% of all cases of HD in HIV-positive patients occurred 
in the age group 40-49 years.  Nevertheless, HD presents with advanced stage with histologically mixed cellularity 
sub-type in most of the patients with AIDS.  
Cervical cancer has recently been recognized as an AIDS defining disease in patients infected with HIV (22).  The 
present study showed that 37.5% (3/8) of all subjects with cervical cancer were HIV infected. Only the invasive, 
histologically undifferentiated squamous cell carcinomas were associated with HIV infection.  Cervical cancer is the 
leading type of malignancy seen in women in most of the developing world including Ethiopia (14, 23, 24). 
Epidemiologically cervical cancer is strongly associated with lifestyles leading to increased risk of sexually 
transmissible infectious agents in addition to HIV (25).  A  lack of effective cancer screening and treatment programs 
(24) in the face of high rate of sexually transmitted infections are among the reasons for the observed high incidence 
of cervical cancers in these countries.  Hence we should anticipate to see more cases of cervical cancer occurring 
among women of the child bearing age group in the face of the growing AIDS epidemic in these countries.  Women 
with newly diagnosed cervical carcinomas, particularly those with advanced disease, should be counseled and offered 
HIV testing.   
The rate of detection of other solid tumors among HIV-positive subjects was small. Although multiple  myeloma 
was reported to occur among AIDS patients (26) and as has also occurred in one of our AIDS patients, these probably 
represent a coincidental occurrence rather than a true association with HIV infection.  None of the three patients with 
oronasopharyngeal malignancies were associated with HIV infection.  A recent report from Sudan (27) agrees with 
our observation.  There is, however, a paucity of one type of  neoplasm in particular, namely hepatocellular carcinoma, 
that one might surmise would be  seen in excess among HIV positive populations. Nevertheless, the emergence of this 
tumor as a significant neoplastic complication of AIDS has not been demonstrated, as is also suggested by others 
(28,29).  
Because of the small number of the cases, the results from the present study should be interpreted with caution.  
However,  this study has demonstrated an increase in the incidence of KS, NHL and HD that is consistent with trends 
in the magnitude of the HIV/AIDS epidemic in Ethiopia (12). Furthermore, the findings confirm that, besides 
opportunistic infections, neoplasms are other important manifestations of AIDS in the country. The data presented 
here demonstrate the need for the awareness  of  clinicians of  neoplastic disorders that are not well recognized as  
AIDS-related neoplasms. With the improved management of opportunistic infections in  AIDS patients and increased 
survival,  many new malignancies will likely continue to be identified.  The  study underscores  the need for well 
designed prospective studies in the future to determine the impact of HIV epidemic on the incidence and pattern of 
neoplastic disorders in the country.    
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